ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver grafts"

  • 2018 American Transplant Congress

    Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes

    L. De Gregorio,1 E. Bugeaud,1 G. Galliano,2 H. Bohorquez,1 D. Bruce,1 I. Carmody,1 A. Cohen,1 J. Seal,1 D. Sonnier,1 A. Mathur,1 G. Loss.1

    1Abdominal Transplant Surgery, Ochsner Clinic Foundation, New Orleans, LA; 2Pathology, Ochsner Clinic Foundation, New Orleans, LA.

    INTRODUCTIONGraft steatosis is a risk factor for early allograft dysfunction (EAD) and is thought to portend inferior transplant outcomes. The impact of total steatosis, combining…
  • 2018 American Transplant Congress

    Liver Allocation: One OPO's Experience with Expedited versus Non-Expedited Placement

    C. Muse, R. Squires, C. Trahan, J. Whaley, J. Orlowski.

    LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK.

    Background: One organ procurement organization (OPO) sought to study expedited versus non-expedited livers recovered/transplanted after local/regional centers declined. The OPO sought to determine relative recipient…
  • 2018 American Transplant Congress

    Outcomes of Moderately Macrosteatotic Liver Allografts

    J. Alvikas, A-.P. Deeb, K. Lemon, X. Chen, S. Malik, G. Zeng, C. Hughes, A. Humar, A. Tevar.

    Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

    Objectives: Liver transplantation remains the only effective long-term treatment option for patients with end-stage liver disease (ESLD). Organs available for ESLD patients are scarce and…
  • 2018 American Transplant Congress

    Subnormothermic Machine Perfusion (SNMP) with Human Hemoglobin(Hb)-Based Oxygen Carriers (HBOCs)perfusate Decreased Hepatocellular Reperfusion Injury of Donation after Cardiac Death (DCD) Donor in Pig Model

    T. Shonaka,1 N. Matsuno,1 H. Obara,2 R. Yoshikawa,2 Y. Nishikawa,3 M. Gochi,1 M. Otani,1 H. Takahashi,1 H. Azuma,3 H. Sakai,4 H. Furukawa.1

    1Department of Surgery, Asahikawa Medical University, Asahikawa, Japan; 2Tokyo Metroporitan University, Tokyo, Japan; 3Asahikawa Medical University, Asahikawa, Japan; 4Nara Medical University, Nara, Japan.

    Subnormothermic machine perfusion (SNMP) alleviate hepatoceller injury during organ preservation. However more oxygen is required when perfusate SNMP. Some studies demonstrated that SNMP with hemoglobin-based…
  • 2018 American Transplant Congress

    Kidney Quality Influences Patient and Graft Survival in Liver Transplant Recipients with End Stage Renal Disease

    J. Reyes, M. Eerhart, J. Danobeita, P. Chlebeck, L. Zitur, L. Fernandez.

    Surgery, University of Wisconsin, Madison.

    Background: Recent changes in the allocation policy established by UNOS created a competitive algorithm that facilitates the placement of kidneys in liver transplant recipients that…
  • 2018 American Transplant Congress

    Risk Factors of De Novo Malignancies after Liver Transplantation

    M. Altieri,1 O. Seree,2 J. Dumortier,3 GREF2 Groupe de Recherche Français en Greffe de Foie.

    1Service d'HepatoGastroenterologie, Nutrition et Oncologie Digestive, CHU de Caen, Caen, France; 2Réseau Régional de Cancérologie Onco-Basse-Normandie, Herouville Saint-Clair, France; 3Service d'HepatoGastroenterologie, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France.

    De novo malignancies after liver transplantation (LT) are one of the leading causes of late mortality, with a reported risk of malignancies twice as high…
  • 2018 American Transplant Congress

    Post Reperfusion Portal Flow Rate Impacts Liver Allograft and Patient Survival in Patients with Pre Transplant Portal Vein Thrombosis

    M. Rizzari, M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud.

    Henry Ford Transplant Institute, Henry Ford Health System, Detroit, MI.

    Background: Pre-transplant (pretx) portal vein thrombosis (PVT) not only makes the technical aspect of liver transplantation more challenging, it also is known to affect outcomes.…
  • 2018 American Transplant Congress

    Chronic Rejection: Risk Factors, Clinical Presentation and Outcome in Pediatric Liver Transplant Recipients: A Single Center Experience

    T. Miloh, A. Cheng, D. Schady, R. Himes, K. Mysore, K. Hosek, J. Goss.

    Texas Children's Hospital, Baylor College of Medicine, Houston, TX.

    Chronic rejection (CR) is the leading indication for long term graft loss. We discuss our centers' experience with CR diagnosis and management. Method: Electronic medical…
  • 2018 American Transplant Congress

    Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?

    C. Hwang,1 S. Levea,2 M. MacConmara.1

    1Surgery, UT Southwestern Medical Center, Dallas, TX; 2Medicine, UT Southwestern Medical Center, Dallas, TX.

    Introduction: Multiple strategies exist to increase the organ pool for livers in pediatric recipients, including using split livers, high risk livers, and donation after cardiac…
  • 2018 American Transplant Congress

    ABO‐incompatible Deceased Donor Liver Transplantation

    X. Luo, C. Haugen, A. Thomas, J. Garonzik-Wang, D. Segev.

    Johns Hopkins, Baltimore, MD.

    ABO-incompatible liver transplantation (ILT) has increased over the past decade despite reports suggesting that adult ILT recipient have worse outcomes than ABO-compatible liver transplant (CLT)…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences